12-month Study of AMG 073 in Renal Osteodystrophy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Renal Osteodystrophy

Interventions

DRUG

AMG 073

30 mg QD orally 50 mg QD orally 70 mg QD orally 90 mg QD orally 120 mg QD orally 180 mg QD orally

DRUG

Placebo

30 mg QD orally 50 mg QD orally 70 mg QD orally 90 mg QD orally 120 mg QD orally 180 mg QD orally